MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

Strona główna・Stock List・Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

8 -1.6

Buy Sell

Overview

Share price change

24h

Current

Min

7.9399999999999995

Max

8.04

Key metrics
By Trading Economics
Income	-69M -102M
Sales	-10M 34M
EPS	-5.69
Profit margin	-299.886
Employees	228
EBITDA	4.7M -18M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+83.82% upside

Market Stats
By TradingEconomics
Market Cap	-15M 142M
Previous open	9.6
Previous close	8

News Sentiment

By Acuity

34%

66%

123 / 348 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 kwi 2026, 17:04 UTC

Major Market Movers

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 kwi 2026, 00:00 UTC

Earnings

Acquisitions, Mergers, Takeovers

Big Yachts, Big Bucks -- Barrons.com

10 kwi 2026, 21:55 UTC

Acquisitions, Mergers, Takeovers

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 kwi 2026, 21:01 UTC

Earnings

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 kwi 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10 kwi 2026, 20:50 UTC

Market Talk

Major News Events

Basic Materials Roundup: Market Talk

10 kwi 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 kwi 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 kwi 2026, 20:10 UTC

Acquisitions, Mergers, Takeovers

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 kwi 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10 kwi 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 kwi 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 kwi 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 kwi 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 kwi 2026, 18:25 UTC

Market Talk

Major News Events

Precious Metals Finish With Weekly Gains -- Market Talk

10 kwi 2026, 18:05 UTC

Market Talk

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 kwi 2026, 17:31 UTC

Market Talk

Major News Events

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 kwi 2026, 17:26 UTC

Earnings

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 kwi 2026, 17:10 UTC

Market Talk

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 kwi 2026, 17:00 UTC

Major News Events

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 kwi 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

10 kwi 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10 kwi 2026, 16:12 UTC

Earnings

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 kwi 2026, 16:11 UTC

Earnings

Partners Group: Traditional Programs Contributed $3.3B

10 kwi 2026, 16:10 UTC

Earnings

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 kwi 2026, 16:10 UTC

Earnings

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10 kwi 2026, 16:10 UTC

Earnings

Partners Group 1Q New Client Demand $8.3B

10 kwi 2026, 16:09 UTC

Earnings

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10 kwi 2026, 15:54 UTC

Acquisitions, Mergers, Takeovers

Plenitude Completes Acquisition of Acea Energia

10 kwi 2026, 15:38 UTC

Market Talk

Global Energy Roundup: Market Talk

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

83.82% upside

12 Months Forecast

Average 15 USD 83.82%

High 28 USD

Low 8 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

There are no events.

Sentiment

By Acuity

123 / 348 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

Other stocks from the sector

MDT

Medtronic PLC

87.11

↓-0.93%

Agilent Technologies Inc

115.09

↓-0.3%

VEEV

Veeva Systems Inc

151.46

↓-3.57%

HQY

HealthEquity Inc

78.12

↓-6.83%

TLRY

Tilray Brands Inc

6.58

↓-1.94%

Karyopharm Therapeutics Inc

Overview

Share price change

Key metrics

Recommendations

Market Stats

News Sentiment

Technical Score

Karyopharm Therapeutics Inc Chart

Related News

Peer Comparison

Karyopharm Therapeutics Inc Forecast

Price Target

Rating Consensus

Technical Score

Sentiment

Financials

Other stocks from the sector